Recurrent and Metastatic HNSCC: New Insights and Real-World Evidence for Improved Patient Outcomes (May 06, 2024)
Live Webinar
May 06, 2024
1 AMA PRA Category 1 Credit™ ...Speakers
OVERVIEW
Recurrent and Metastatic HNSCC: New Insights and Real-World Evidence for Improved Patient Outcomes is organized by i3 Health and will be held on May 06, 2024.
Statement of Need:
Head and neck cancers represent a heterogeneous group of tumors that originate in the lip/oral cavity, hypopharynx, oropharynx, nasopharynx, and larynx. An estimated 66,470 new cases are diagnosed in the United States annually, and 15,050 people die of the disease (Siegel et al, 2022). Approximately 90% of cases are classified as head and neck squamous cell carcinoma (HNSCC). Treatment of HNSCC is complicated by numerous factors, including differing therapeutic strategies based on tumor location and stage, human papillomavirus (HPV) status, the need to preserve surrounding organs and tissues, and impacts on quality of life (NCCN, 2023). Remaining up to date on emerging treatment options and management strategies for HNSCC is vital. This live webinar, led by Assuntina Sacco, MD, Associate Professor of Medicine at Moores Cancer Center of UC San Diego Health, will provide new insights and real-world guidance for improved outcomes in recurrent and metastatic HNSCC.
Learning Objectives:
Upon completion of this activity, participants should be able to
- Distinguish histopathological, molecular, and clinical biomarkers that can inform prognosis and management of HNSCC
- Incorporate emerging efficacy and safety data on novel immune checkpoint inhibitors into personalized care plans for patients with advanced recurrent/metastatic HNSCC
- Apply strategies to prevent and mitigate immune-mediated adverse events
- Evaluate supportive care measures that can help optimize survivorship care in patients who have received treatment for advanced recurrent/metastatic HNSCC
KEY DATES
06 May, 2024
Event Start Date
06 May, 2024
Event End Date
ACCREDITATION & CREDITS
Jointly Accredited Provider
In support of improving patient care, i3 Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
i3 Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By providing this information, participants are agreeing to allow i3 Health to share this information with the ACCME.
Physician Assistants
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities approved for AMA PRA Category 1 Credit™ from organizations accredited by ACCME. Physician assistants may receive a maximum of 1.0 hours of Category 1 credit for completing this program.
Nurse Practitioners
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Nursing Continuing Professional Development
A maximum of 1.0 ANCC contact hour may be earned by learners who successfully complete this nursing continuing professional development activity. This activity has been designated for 0.9 ANCC contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.
Provider approved by the California Board of Registered Nursing, Provider Number 15824, for 1.0 ANCC contact hour.
TARGET AUDIENCE
PhysicianNursingPhysician AssistantNurse AssistantsPrimary Care PractitionersOtolaryngology-head and neck surgeryMedical OncologistsPrimary Care ProvidersPractice NursesSPECIALITIES
Primary CarePrimary Care PhysiciansNurse PractitionerPhysician AssistantsPulmonologistsOtolaryngologyOtolaryngology Head and Neck SurgeryOtorhinolaryngologyOtorhinolaryngology NurseNeurotologyHead and Neck OncologyHead and Neck SurgeryPsychiatryRELATED CONFERENCES & LIVE WEBINARS
1 AMA PRA Category 1 Credit™
...
...
Quick Links